Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R21) | Apply Online

Opportunity Summary:

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), released the funding opportunity announcement titled "Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R21)" (Funding Opportunity Number PA-09-200) to support exploratory research focused on non-coding RNAs (ncRNAs) in preneoplastic conditions and very early-stage cancers. The central idea is to speed up discovery and early proof-of-concept work on ncRNA-based targets or signatures that could make it easier to detect cancer earlier, intervene sooner, and ultimately prevent progression to invasive disease. A major emphasis is placed on understanding how ncRNAs behave in lesions that are not yet cancer but have the potential to become cancer, because that is where better biomarkers and actionable biological insights could have the biggest impact on screening and prevention strategies.

The scientific goals outlined in the announcement prioritize three closely related outcomes. First, the FOA encourages studies that discover and characterize ncRNAs that can improve early detection, intervention, and prevention, which can include identifying ncRNA patterns that appear before traditional clinical or histologic changes are obvious. Second, it seeks research that can help predict which preneoplastic lesions are more likely to progress to cancer, addressing the real clinical problem that many early lesions never become dangerous while a smaller subset does. Third, it supports work aimed at distinguishing benign lesions from true precancerous lesions, which is important for reducing overtreatment and improving clinical decision-making. In practice, this means applicants are expected to propose projects that connect ncRNA findings to meaningful early disease states and clinically relevant questions about risk, progression, and classification.

The award mechanism is the NIH R21 exploratory/developmental grant, which is designed for early-stage, high-impact, and sometimes higher-risk projects that may not yet have extensive preliminary data. This mechanism typically supports shorter, more focused research efforts intended to generate initial findings that can justify larger follow-on studies. The FOA also notes it runs in parallel with an R01 opportunity (PA-09-199) of the same scientific scope, signaling that investigators with more mature projects could consider the R01 route, while this R21 targets exploratory discovery and early validation work.

From a funding and award structure standpoint, the announcement does not commit to a fixed number of awards and makes clear that both the number and size of awards depend on the mix of applications received, their scientific quality, their proposed duration, and their budgets. The listed award ceiling is $200,000. There is no cost sharing or matching requirement, which reduces barriers for applicants by not requiring institutional funds to be committed as a condition of receiving the grant.

Eligibility is broad and includes many common research-performing organizations. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including those with 501(c)(3) status and certain nonprofits without 501(c)(3) status), for-profit organizations other than small businesses, and small businesses. The announcement also allows additional categories such as eligible federal agencies and non-U.S. (foreign) organizations, reflecting NIH's willingness to fund strong science regardless of whether it originates domestically, as long as it fits program goals and meets NIH requirements.

Administratively, this opportunity falls under the discretionary grant category and is associated with CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.394 (Cancer Detection and Diagnosis Research, indicating its dual alignment with prevention and detection priorities). The FOA was posted and created on June 1, 2009, and it originally closed on September 7, 2012, with an archive date of October 8, 2012, meaning it is no longer active for new submissions under that specific announcement. The full archived announcement was available through NIH at the provided link (http://grants.nih.gov/grants/guide/pa-files/PA-09-200.html), and the NIH Office of Extramural Research (OER) webmaster contact was provided for technical access and linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R01)

Previous opportunity: Biomarkers for Early Detection of Hematopoietic Malignancies (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 09 200

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 09 200) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 200", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.